26 January 2026 - The EMA has published a draft agenda for this week's CHMP meeting. ...
20 January 2026 - This guidance provides recommendations to sponsors about using minimal residual disease and complete response in multiple myeloma ...
12 January 2026 - The US FDA today published draft guidance designed to facilitate the use of Bayesian methodologies in ...
9 January 2026 - The Department of Health has published an updated agenda for the March 2026 PBAC agenda (version ...
22 December 2025 - The PBS Expenditure and Prescriptions Report 1 July 2024 to 30 June 2025 is now available. ...
24 December 2025 - The Public Summary Documents (positive recommendations) from the September 2025 PBAC meeting are now available. ...
19 December 2025 - With the General Methods 8.0, the new IQWiG methodology for determining minimum staffing levels for service ...
19 December 2025 - Recommendations made by the PBAC in November 2025 relating to the listing of medicines on the ...
18 December 2025 - The final PBAC update for 2025 is now available. ...
16 December 2025 - Independent committee voted unanimously on the positive net health benefit of all three treatments; final report ...
11 December 2025 - Cytisinicline is effective for smoking cessation; a 12 week course of cytisinicline would be cost effective ...
10 December 2025 - Public comment period now open until 14 January 2026; Requests to make oral comment during public ...
8 December 2025 - The EMA has published a draft agenda for this week's CHMP meeting. ...
5 December 2025 - The agenda for the December 2025 PBAC meeting is now available. ...
3 December 2025 - The utilisation analysis public release documents from the June 2025 DUSC meeting are now available. ...